Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease

    Diabetes Date published:

  • Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review

    Diabetes Research and Clinical Practice Date published:

  • Renal trials in diabetes need a platform: time for a global approach?

    The Lancet Diabetes & Endocrinology Date published:

  • Baseline characteristics and enrichment results from the SONAR trial

    Diabetes, Obesity and Metabolism Date published:

  • Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease

    Clinical Journal of the American Society of Nephrology Date published:

  • Abstract #233 Outcomes with Canagliflozin in Patients By Age Subgroups: Results from the Canvas Program

    Endocrine Practice Date published:

  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk

    Cardiovascular Diabetology Date published:

  • Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

    European Heart Journal Date published:

  • Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

    Diabetes, Obesity and Metabolism Date published:

  • Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology

    Kidney International Supplements Date published:

  • Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events

    Circulation Date published:

  • Associations between body mass index and the risk of renal events in patients with type 2 diabetes

    Nutrition & Diabetes Date published:

  • CANAGLIFLOZIN AND RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

    Date published:

  • RELATIVE CONTRIBUTIONS TO MAJOR DIALYSIS RANDOMISED CONTROLLED TRIALS FROM TEN GLOBAL REGIONS

    Date published:

  • FACTORS ASSOCIATED WITH REGRESSION OF LEFT VENTRICULAR MASS INDEX IN THE ACTIVE DIALYSIS TRIAL

    Date published:

  • IMPACT OF EXTENDED HOURS DIALYSIS ON UTILITY-BASED QUALITY OF LIFE: RESULTS FROM THE ACTIVE DIALYSIS TRIAL

    Date published: